Sep 04, 2025
Grünenthal PRO is joining SHL Medical's alliance partnership network to offer final assembly service for Molly® autoinjectors
Jun 02, 2025
Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia
Jan 09, 2025
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
Nov 07, 2024
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Oct 22, 2024
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Jul 17, 2024
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
Feb 12, 2021
Grünenthal successfully extends its term loan bank facilities
Feb 10, 2021
Grünenthal closes deal with AstraZeneca for European rights to CRESTOR(TM) (rosuvastatin)
Dec 16, 2020
Peripheral NOP agonist addressing chronic peripheral neuropathic pain enters clinical development
Dec 01, 2020
Grünenthal agrees to acquire European rights to CRESTOR(TM) (rosuvastatin) from AstraZeneca
Jul 21, 2020
Grünenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA® for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
Feb 04, 2020
Grünenthal Invests in e-mobility at Headquarters in Aachen
Jan 29, 2020
Grünenthal Expands Its Network Through Innovation Hub in Boston
Dec 10, 2019
Jan Adams Appointed Chief Scientific Officer for Grünenthal
May 02, 2019
Five Young Scientists Win EFIC-Grünenthal Grant 2018
Jan 22, 2019
Grünenthal: Fabian Raschke Appointed Chief Financial Officer (CFO)
Dec 14, 2018
Grünenthal and OnDosis Team Up for Individualised Dosing of Oral Drugs in Pain Management to Increase Patient Safety
Nov 14, 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Nov 05, 2018
Grünenthal Acquires Global Rights for Qutenza®
Oct 30, 2018
Grünenthal Agrees US$ 922 m Deal With AstraZeneca for Nexium and Vimovo